Drugs 2 Flashcards
raloxifene contraindications
past medical history of deep venous thrombosis, renal vein thrombosis, pulmonary embolism, malignancy, ***active smoking, or any thrombophilia
cetuximab, panitumumab MOAs
EGFR inhibitors
PARP inhibitors
olaparib
checkpoint inhibitor targets
CTLA-4 inhibitors, PD-1 inhibitors, PD-L1 inhibitors, LAG-3,
how PARP inhibitors work
Formation of double-stranded DNA breaks that in BRCA-competent tumors are repaired by homologous recombination. Tumors with germline BRCA mutations are unable to repair these defects, leading to cell death (referred to as synthetic lethality).
Platinum based chemotherapy agents
Cisplatin, carboplatin, oxaliplatin
How do platinum antineoplastics work
DNA cross linking, which inhibits DNA repair and synthesis in tumor cells
Cisplatin toxicity
Neurotoxic, neuropathy, ototoxocity, hemolytic anemia, nausea and vomiting (very emetogenic)
paclitaxel trade name
taxol
paclitaxel SE’s
peripheral neuropathy, alopecia, N/V, neutropenia, diarrhea, mouth sores
aloxi generic name
palonosetron hydrochloride
FOLFOX
leucovorin calcium (folinic acid), fluorouracil, and oxaliplatin.
bevacizumab trade name
avastin
bevacizumab SE profile
- epistaxis, headache, HTN, rhinitis, proteinuria, taste alteration, dry skin, rectal
hemorrhage, lacrimation disorder, back pain and exfoliative dermatitis. - myelosuppression
RvD treatment includes
Bortezomib (Velcade) plus lenalidomide (Revlimid) and dexamethasone (VRd) (1 g q month)
xgeva generic name
denosumab
revlimid generic name
lenalidomide
zometa generic name
zoledronic acid
PDL-1 inhibitors
atezolizumab, avelumab, durvalumab,
hereditary breast cancer syndromes
Approximately 80%–90% of hereditary breast cancer cases are caused by mutations in the BRCA1 and BRCA2 genes. Other important clinical genetic predispositions include Cowden syndrome, Li-Fraumeni syndrome, Peutz-Jeghers syndrome, and ataxia-telangiectasia.
BRCA2 cancers
breast, ovarian, prostate, pancreatic
BRCA1 cancer predispositions
breast, ovarian, bowel, prostate
what is leucovorin
folinic acid
irinotecan class
topoisomerase inhibitor